366 related articles for article (PubMed ID: 24113492)
1. Clinical venous thromboembolism following joint surgery: effect of extended thromboprophylaxis on its annual frequency and postoperative pattern over 22 years.
Dahl OE; Gudmundsen TE; Pripp AH; Aanesen JJ
Clin Appl Thromb Hemost; 2014 Mar; 20(2):117-23. PubMed ID: 24113492
[TBL] [Abstract][Full Text] [Related]
2. Population-based epidemiology of postoperative venous thromboembolism in Taiwanese patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis.
Wu PK; Chen CF; Chung LH; Liu CL; Chen WM
Thromb Res; 2014 May; 133(5):719-24. PubMed ID: 24593913
[TBL] [Abstract][Full Text] [Related]
3. [Prophylaxis of venous thromboembolism in orthopedic surgery].
Giuseppini MU; Guiducci S; Bardelli M
Minerva Med; 2010 Feb; 101(1):49-58. PubMed ID: 20228720
[TBL] [Abstract][Full Text] [Related]
4. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.
Schiff RL; Kahn SR; Shrier I; Strulovitch C; Hammouda W; Cohen E; Zukor D
Chest; 2005 Nov; 128(5):3364-71. PubMed ID: 16304285
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study.
Mismetti P; Samama CM; Rosencher N; Vielpeau C; Nguyen P; Deygas B; Presles E; Laporte S;
Thromb Haemost; 2012 Jun; 107(6):1151-60. PubMed ID: 22476471
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism prophylaxis after total knee or hip replacement: treatment pattern and outcomes.
Penning-van Beest FJ; Overbeek JA; Meijer WM; Woodruff K; Jackson J; van der Vis H; van der Linden P; Herings RM
Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):972-8. PubMed ID: 21748826
[TBL] [Abstract][Full Text] [Related]
7. Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery.
Dranitsaris G; Stumpo C; Smith R; Bartle W
Am J Cardiovasc Drugs; 2009; 9(1):45-58. PubMed ID: 19178131
[TBL] [Abstract][Full Text] [Related]
8. Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.
Vekeman F; LaMori JC; Laliberté F; Nutescu E; Duh MS; Bookhart BK; Schein J; Dea K; Olson WH; Lefebvre P
J Med Econ; 2011; 14(3):324-34. PubMed ID: 21506632
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism rates in patients undergoing major hip and knee joint surgery at Waitemata District Health Board: a retrospective audit.
Dixon J; Ahn E; Zhou L; Lim R; Simpson D; Merriman EG
Intern Med J; 2015 Apr; 45(4):416-22. PubMed ID: 25644232
[TBL] [Abstract][Full Text] [Related]
10. Frequency and timing of clinical venous thromboembolism after major joint surgery.
Bjørnarå BT; Gudmundsen TE; Dahl OE
J Bone Joint Surg Br; 2006 Mar; 88(3):386-91. PubMed ID: 16498018
[TBL] [Abstract][Full Text] [Related]
11. The ''critical thrombosis period'' in major orthopedic surgery: when to start and when to stop prophylaxis.
Warwick D; Rosencher N
Clin Appl Thromb Hemost; 2010 Aug; 16(4):394-405. PubMed ID: 20019020
[TBL] [Abstract][Full Text] [Related]
12. Incidence of venous thromboembolism after total hip, total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit.
Millar JS; Lawes CM; Farrington B; Andrew P; Misur P; Merriman E; Walker M
N Z Med J; 2020 Mar; 133(1511):52-60. PubMed ID: 32161421
[TBL] [Abstract][Full Text] [Related]
13. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3,954 patients.
Dahl OE; Gudmundsen TE; Bjørnarå BT; Solheim DM
Acta Orthop Scand; 2003 Jun; 74(3):299-304. PubMed ID: 12899550
[TBL] [Abstract][Full Text] [Related]
14. The study of the thrombin generation mechanism and the effect of low molecular weight heparin as thromboprophylaxis in patients undergoing total knee and hip replacement.
Gionis MN; Ioannou CV; Katsamouris AN; Katonis P; Balalis K; Sfyridaki K; Elalamy I; Gerotziafas GT
Thromb Res; 2013; 132(6):685-91. PubMed ID: 24182549
[TBL] [Abstract][Full Text] [Related]
15. Trends of thromboprophylaxis and complications after major lower limb orthopaedic surgeries in Korea: National Health Insurance Claim Data.
Kim S; Ahn H; Shin SA; Park JH; Won CW
Thromb Res; 2017 Jul; 155():48-52. PubMed ID: 28486159
[TBL] [Abstract][Full Text] [Related]
16. Assessing the quality of pharmacological treatments from administrative databases: the case of low-molecular-weight heparin after major orthopaedic surgery.
Gerkens S; Beguin C; Crott R; Closon MC; Horsmans Y
J Eval Clin Pract; 2008 Aug; 14(4):585-94. PubMed ID: 18462276
[TBL] [Abstract][Full Text] [Related]
17. The risk of venous thromboembolism, myocardial infarction, stroke, major bleeding and death in patients undergoing total hip and knee replacement: a 15-year retrospective cohort study of routine clinical practice.
Pedersen AB; Mehnert F; Sorensen HT; Emmeluth C; Overgaard S; Johnsen SP
Bone Joint J; 2014 Apr; 96-B(4):479-85. PubMed ID: 24692614
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
[TBL] [Abstract][Full Text] [Related]
19. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
20. Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement.
Selby R; Borah BJ; McDonald HP; Henk HJ; Crowther M; Wells PS
Thromb Res; 2012 Aug; 130(2):166-72. PubMed ID: 22365491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
